Seraseq Tri-Level Tumor Mutation DNA Mix v2 HC
Classification
- Category
- Sequencing & Genomics
- Product Type
- Assay Kit
- Technology
- Next-Generation Sequencing
Application
- Application Area
- Oncology Markers
Regulatory Status
RUO
Reported from manufacturer sources and not independently verified.
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
The Seraseq Tri-Level Tumor Mutation DNA Mix v2 (HC) is formulated for use with targeted next-generation sequencing (NGS) assays that detect mutations in key oncogenes and tumor suppressor genes.
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-17
2026-10-17
availability varies